Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

Pharmacokinetics of lidocaine and its metabolite in peridural anesthesia administered to pregnant women with gestational diabetes mellitus (2008)

  • Authors:
  • USP affiliated authors: CAVALLI, RICARDO DE CARVALHO - FMRP ; LANCHOTE, VERA LUCIA - FCFRP ; DUARTE, GERALDO - FMRP ; CUNHA, SERGIO PEREIRA DA - FMRP
  • USP Schools: FMRP; FCFRP; FMRP; FMRP
  • DOI: 10.1007/s00228-008-0544-0
  • Subjects: DIABETES MELLITUS; ANESTESIA OBSTÉTRICA; GRAVIDEZ
  • Language: Inglês
  • Imprenta:
  • Source:
  • Acesso online ao documento

    DOI or search this record in
    Informações sobre o DOI: 10.1007/s00228-008-0544-0 (Fonte: oaDOI API)
    • Este periódico é de assinatura
    • Este artigo NÃO é de acesso aberto
    • Cor do Acesso Aberto: closed
    Informações sobre o Citescore
  • Título: European Journal of Clinical Pharmacology

    ISSN: 0031-6970

    Citescore - 2017: 2.69

    SJR - 2017: 1.159

    SNIP - 2017: 1.277


  • Exemplares físicos disponíveis nas Bibliotecas da USP
    BibliotecaCód. de barrasNúm. de chamada
    FMRP11200053475-Spcd 1715749
    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      MOISÉS, Elaine Christine Dantas; DUARTE, Luciana de Barros; CAVALLI, Ricardo de Carvalho; et al. Pharmacokinetics of lidocaine and its metabolite in peridural anesthesia administered to pregnant women with gestational diabetes mellitus. Euroepan Journal of Clinical Pharmacology, Heidelberg, v. 64, n. 12, p. 1189-1196, 2008. DOI: 10.1007/s00228-008-0544-0.
    • APA

      Moisés, E. C. D., Duarte, L. de B., Cavalli, R. de C., Marques, M. P., Lanchote, V. L., Duarte, G., & Cunha, S. P. da. (2008). Pharmacokinetics of lidocaine and its metabolite in peridural anesthesia administered to pregnant women with gestational diabetes mellitus. Euroepan Journal of Clinical Pharmacology, 64( 12), 1189-1196. doi:10.1007/s00228-008-0544-0
    • NLM

      Moisés ECD, Duarte L de B, Cavalli R de C, Marques MP, Lanchote VL, Duarte G, Cunha SP da. Pharmacokinetics of lidocaine and its metabolite in peridural anesthesia administered to pregnant women with gestational diabetes mellitus. Euroepan Journal of Clinical Pharmacology. 2008 ; 64( 12): 1189-1196.
    • Vancouver

      Moisés ECD, Duarte L de B, Cavalli R de C, Marques MP, Lanchote VL, Duarte G, Cunha SP da. Pharmacokinetics of lidocaine and its metabolite in peridural anesthesia administered to pregnant women with gestational diabetes mellitus. Euroepan Journal of Clinical Pharmacology. 2008 ; 64( 12): 1189-1196.

    Referências citadas na obra
    Alberti KGMM, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabet Med 15:539–553
    Bargetzi MJ, Aoyama T, Gonzalez FJ, Meyer UA (1989) Lidocaine metabolism in human liver microsomes by cytochrome P450IIIA4. Clin Pharmacol Therap 46:521–527
    Bernards CM (2001) Epidural and spinal anesthesia. In: Barash PG, Cullen BF, Stoelting RK (eds) Clinical anesthesia, 4th edn. Lippincott Williams & Wilkins, Philadelphia, pp 1–43
    Braid DP, Scott DB (1966) Dosage of lignocaine in epidural block in relation to toxicity. Br J Anaesth 38:596–602
    Cavalli RC, Lanchote VL, Duarte G, Moisés ECD, Prado MFM, Duarte LB, Cunha SP (2004) Pharmacokinetics and transplacental transfer of lidocaine and its metabolite for perineal analgesic assistance to pregnant women. Eur J Clin Pharmacol 60:569–574
    Cheng PY, Morgan ET (2001) Hepatic cytochrome P450 regulation in disease states. Curr Drug Metab 2:165–183
    Downing JW, Johnson HV, Gonzalez HF, Arney TL, Herman NL, Johnson RF (1997) The pharmacokinetics of epidural lidocaine and bupivacaine during cesarean section. Anesth Analg 84:527–532
    Emami J, Passutto FM, Jamali F (1998) Effect of experimental diabetes mellitus and arthritis on the pharmacokinetics of hydroxychloroquine enantiomers in rats 15(6):897–903
    Gilman GA, Hardman JG, Limbird LE (2001) Goodman and Gilman’s the pharmacological basis of therapeutics, 10th edn. McGraw-Hill, New York
    Hodgkinson R, Husain FJ (1980) Obesity and cephalad spread of analgesia following epidural administration of bupivacaine for cesarean section. Anesth Analg 59:89–92
    Iber H, Li-Masters T, Chen Q, Yu S, Morgan ET (2001) Regulation of hepatic cytochrome P450 2C11 via cAMP: implications for down-regulation in diabetes, fasting and inflammation. J Pharmacol Exp Therap 297:174–180
    Isohanni MH, Neuronen PJ, Palkama VJ, Olkkola KT (1998) Effect of erythromycin and itraconazole on the pharmacokinetics of intravenous lignocaine. Eur J Clin Pharmacol 54:561–565
    Kivisto KT, Kroemer HK (1997) Use of probe drugs as predictors of drug metabolism in humans. J Clin Pharmacol 37(1 Suppl):S40–S48
    Little BB (1999) Pharmacokinetics during pregnancy: evidence-based maternal dose formulation. Obstet Gynecol 93:858–868
    Marques MP, Coelho EB, Dos Santos NA, Geleilete TJ, Lanchote VL (2002) Dynamic and kinetic disposition of nisoldipine enantiomers in hypertensive patients presenting with type-2 diabetes mellitus. Eur J Clin Pharmacol 58:607–614
    Nattel S, Gagne G, Pineau M (1987) The pharmacokinetics of lignocaine and b-adrenoreceptor antagonists in patients with acute myocardial infarction. Clinl Pharmacokinet 13:293–316
    Orlando R, Piccoli P, De Martin S, Padrini R, Palatini P (2003) Effect of the CYP3A4 inhibitor erythromycin on the pharmacokinetics of lignocaine and its pharmacologically active metabolites in subjects with normal and impaired liver function. Br J Clin Pharmacol 55:86–93
    Preston RA, Chung M, Gaffney M, Alonso A, Baltodano NM, Epstein M (2001) Comparative pharmacokinetics and pharmacodynamics of amlodipine in hypertensive patients with and without type II diabetes mellitus. J Clin Pharmacol 41:1215–1224
    Preston RA, Epstein M (1999) Effects of diabetes on cardiovascular drug metabolism. Emerging clinical implications. Diabetes Care 22:982–988
    Ramanathan J, Bottorff M, Jeter JN, Khalil M, Sibai BM (1986) The pharmacokinetics and maternal and neonatal effects of epidural lidocaine in preeclampsia. Anesth Analg 65:120–126
    Reynolds F, Taylor C (1970) Maternal and neonatal blood concentrations of bupivacaine: a comparison with lignocaine during continuous epidural analgesia. Anesthesia 25:14–23
    Schenkman JB (1991) Induction of diabetes and evaluation of diabetic state on P450 expression. Methods Enzymol 206:325–331
    Shimojo N (1994) Cytochrome P450 changes in rats with streptozotocin-induced diabetes. Int J Biochem 26:1261–1268
    Sotaniemi EA, Rautio A, Bäckstron M, Arvela P, Pelkonen O (1995) CYP3A4 and CYP2A6 activities marked by the metabolism of lignocaine and coumarin in patients with liver and kidney diseases and epileptic patients. Br J Clin Pharmacol 39:71–76
    Sweetman SC (2002) Martindale: the complete drug reference, 33rd edn. Pharmaceutical Press, London
    Wang JS, Backman JT, Wen X, Taavitsainen P, Neuvonen PJ, Kivisto KT (1995) Fluvoxamine is a more potent inhibitor of lidocaine metabolism than ketoconazole and erythromycin in vitro. Pharmacol Toxicol 85:201–205
    Wang JS, Backman JT, Taavitsainen P, Neuvonen PJ, Kivisto KT (2000) Involvement of CYP1A2 and CYP3A4 in lidocaine n-deethylation and 3-hydroxylation in humans. Drug Metab Disp 25:959–965
    Wildsmith JA, Strichartz C (1984) Local anaesthetic drugs - an historical perspective. Br J Anaesth 56:937–939
    Wildt SN, Kearns GL, Leeder JS, Van den Anker JN (1999) Cytochrome P450 3A. Ontogeny and drug disposition. Clin Pharmacokinet 37:485–505
    Woodcroft KJ, Novak RF (1999) Insulin differentially affects xenobiotic-enhanced, cytochrome P-450 (CYP)2E1, CYP2B, CYP3A, and CYP4A expression in primary cultured rat hepatocytes. J Pharmacol Exp Therap 289:1121–1127
    Woodcroft KJ, Novak RF (1999) The role of phosphatidylinositol 3-kinase, Src kinase, and protein kinase A signaling pathways in insulin and glucagon regulation of CYP2E1 expression. Biochem Biophys Res Comm 266:304–307